Open-label placebo is an evidence-based treatment option for many chronic conditions.
Ballou, Sarah, and Tobias Kube. 2024. “Open-Label Placebo Is an Evidence-Based Treatment Option for Many Chronic Conditions.”. Pain 165 (2): 487-88.
Search
Search results
172 results found
Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission.
George, Lauren A, Harris T Feldman, Madeline Alizadeh, Ameer Abutaleb, Samantha Zullow, Ashley Hine, Kristen Stashek, et al. 2023. “Histologic Inflammation Can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission.”. Crohn’s & Colitis 360 5 (4): otad059.
Sex differences impact ergonomic endoscopic training for gastroenterology fellows.
Suhail, Fathima K, Yuying Luo, Kevin Williams, Rashmi Advani, Kirsti Campbell, Katie Dunleavy, Anam Rizvi, Alana Persaud, Renee L Williams, and Loren G Rabinowitz. 2024. “Sex Differences Impact Ergonomic Endoscopic Training for Gastroenterology Fellows.”. Gastrointestinal Endoscopy 99 (2): 146-154.e1.
Parental Leave and Return-to-Work Policies: A Practical Model for Implementation in Gastroenterology.
Feld, Lauren D, Amy S Oxentenko, Dawn Sears, Aline Charabaty, Loren G Rabinowitz, and Julie K Silver. 2023. “Parental Leave and Return-to-Work Policies: A Practical Model for Implementation in Gastroenterology.”. Gastroenterology 165 (4): 813-18.
A primer on common supplements and dietary measures used by patients with inflammatory bowel disease.
Minhas, Hadi J, Konstantinos Papamichael, Adam S Cheifetz, and Robert J Gianotti. 2023. “A Primer on Common Supplements and Dietary Measures Used by Patients With Inflammatory Bowel Disease.”. Therapeutic Advances in Chronic Disease 14: 20406223231182367.
Safety of Biologic and Small Molecule Therapy for Inflammatory Bowel Disease Among Solid Organ Transplant Recipients: Systematic Review and Meta-Analysis.
Taneja, Vikas, Rajsavi S Anand, Mohammed El-Dallal, Jeffrey Dong, Nisa Desai, Isha Taneja, and Joseph D Feuerstein. 2024. “Safety of Biologic and Small Molecule Therapy for Inflammatory Bowel Disease Among Solid Organ Transplant Recipients: Systematic Review and Meta-Analysis.”. Inflammatory Bowel Diseases 30 (4): 585-93.
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
Yarur, Andres J, Maria T Abreu, Parakkal Deepak, Poonam Beniwal-Patel, Konstantinos Papamichael, Byron Vaughn, Alexandra Bruss, et al. 2023. “Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.”. The American Journal of Gastroenterology 118 (11): 2005-13.
Symptom Subgroups Taking Into Account Psychological Burden Predicts Irritable Bowel Syndrome Disease Impact and Burden: A Step Forward?
Corsetti, Maura, and Sarah Ballou. 2024. “Symptom Subgroups Taking Into Account Psychological Burden Predicts Irritable Bowel Syndrome Disease Impact and Burden: A Step Forward?”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 22 (2): 237-40.
Relationships of hospitalization outcomes and timing to endoscopy in non-variceal upper gastrointestinal bleeding: A nationwide analysis.
Weissman, Simcha, Muhammad Aziz, Ayrton I Bangolo, Dean Ehrlich, Arnold Forlemu, Anthony Willie, Manesh K Gangwani, et al. 2023. “Relationships of Hospitalization Outcomes and Timing to Endoscopy in Non-Variceal Upper Gastrointestinal Bleeding: A Nationwide Analysis.”. World Journal of Gastrointestinal Endoscopy 15 (4): 285-96.
The overall quality of evidence of recommendations surrounding nutrition and diet in inflammatory bowel disease.
Weissman, Simcha, Brian M Fung, Ayrton Bangolo, Atif Rashid, Badar F Khan, Aditya K Gudimella Tirumala, Sneha Nagpaul, et al. 2023. “The Overall Quality of Evidence of Recommendations Surrounding Nutrition and Diet in Inflammatory Bowel Disease.”. International Journal of Colorectal Disease 38 (1): 98.